It is noteworthy that the increased HIF-1α expression has been correlated with a worse prognosis of breast cancer patients, while CREB increased the risk of metastases in HER-2/neu+ breast cancer (Supplementary Figure 2 and Supplementary Table 1). This evidence concerns the gene ERBB2 and breast cancer.